October 21, 2019
3 min watch
Save
VIDEO: How to affect care in retina patients
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
SAN FRANCISCO — At the American Academy of Ophthalmology meeting, Daniela Ferrara, MD, MSc, PhD, senior medical director for Genentech/Roche, discusses the company’s ophthalmology personalized health care program intended to improve outcomes for patients with retinal diseases.